Dose Volume Analysis of Radiotherapy for Inoperable Patientswith Stage I-II Endometrial Carcinoma

Journal of Radiation Research

Volumn 52, Issue 5, 2011, Pages 666-673

  Ohkubo, Yu ^a   Kato, Shingo ^b   Kiyohara, Hiroki ^b   Tsuruoka, Ichiro ^b   Tamaki, Tomoaki ^c   Noda, Shin ei ^d   Ohno, Tatsuya ^e   Nakano, Takashi ^d  

^a Hidaka Hospital   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^c INTERNATIONAL ATOMIC ENERGY AGENCY   (Austria)

^d GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e GUNMA UNIVERSITY HEAVY ION MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTERIZED TOMOGRAPHY; ONCOLOGY; RISK ASSESSMENT; TOXICITY; TUMORS;

BRACHYTHERAPY; CLINICAL TARGET VOLUMES; CT IMAGE; ENDOMETRIAL CARCINOMAS; GROSS TUMOR VOLUME; HIGH DOSE RATE; IMAGE-BASED; LATE TOXICITIES; RADIOTHERAPY ALONE; STAGE I;

RADIOTHERAPY;

EID: 80053364908     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1269/jrr.11024     Document Type: Article

References (29)

1. Algan O, et al (1996) Improved outcome in patients treated with postoperative radiation therapy for pathologic stage I/II endometrial cancer. Int J Radiat Oncol Biol Phys 35: 925-933.
2. Creutzberg CL, et al (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 355: 1404-1411.
3. Blake P, et al (2009) Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet 373: 137-146.
4. Diavolitsis V, et al (2009) The role of adjuvant radiation in endometrial cancer. Oncology (Williston Park) 23: 342-349.
5. Chao CK, et al (1996) Medically inoperable stage I endometrial carcinoma: a few dilemmas in radiotherapeutic management. Int J Radiat Oncol Biol Phys 34: 27-31.
6. Beriwal S, et al (2006) Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer. Technol Cancer Res Treat 5: 521-527.
7. Shenfield CB, et al (2009) The management of inoperable Stage I endometrial cancer using intracavitary brachytherapy alone: a 20-year institutional review. Brachytherapy 8: 278-283.
8. Taghian A, et al (1988) Radiation therapy alone for medically inoperable patients with adenocarcinoma of the endometrium. Int J Radiat Oncol Biol Phys 15: 1135-1140.
9. Knocke TH, et al (1997) Primary treatment of endometrial carcinoma with high-dose-rate brachytherapy: results of 12 years of experience with 280 patients. Int J Radiat Oncol Biol Phys 37: 359-365.
10. Niazi TM, et al (2005) Long-term results of high-dose-rate brachytherapy in the primary treatment of medically inoperable stage I-II endometrial carcinoma. Int J Radiat Oncol Biol Phys 63: 1108-1113.
11. Weitmann HD, et al (2005) Pilot study in the treatment of endometrial carcinoma with 3D image-based high-dose-rate brachytherapy using modified Heyman packing: clinical experience and dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 62: 468-478.
12. Coon D, et al (2008) High-dose-rate Rotte "Y" applicator brachytherapy for definitive treatment of medically inoperable endometrial cancer: 10-year results. Int J Radiat Oncol Biol Phys 71: 779-783.
13. Haie-Meder C, et al (2005) Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 74: 235-245.
14. Lang S, et al (2006) Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC-ESTRO recommendations. Radiother Oncol 78: 185-193.
15. Potter R, et al (2006) 3D conformal HDR-brachy- and external beam therapy plus simultaneous cisplatin for high-risk cervical cancer: clinical experience with 3 year follow-up. Radiother Oncol 79: 80-86.
16. Viswanathan AN, et al (2007) Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys 68: 491-498.
17. Dimopoulos JC, et al (2009) Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys 75: 56-63.
18. Nakano T, et al (2010) Current advancement in radiation therapy for uterine cervical cancer. J Radiat Res 51: 1-8.
19. Bond MG, et al (1997) Dosimetric considerations in the treatment of inoperable endometrial carcinoma by a high dose rate afterloading packing technique. Clin Oncol 9: 41-47.
20. Mock M, et al (1998) Analysis of different application systems and CT-controlled planning variants in treatment of primary endometrial carcinomas. Is brachytherapy treatment of the entire uterus technically possible? Strahlenther Onkol 174: 320-328.
21. Cox JD, Stetz J and Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31: 1341-1346.
22. Stitt JA (1991) Dose specification for inoperable endometrial carcinoma: The Madison system. Brachytherapy J 2: 32-34.
23. Rotte K (1992) Modified Heyman technique HDR brachytherapy for endometrial cancer. In: Mould RF ed. Brachytherapy in the nordic countries. pp. 16-18.Veenendaal; Nucleotron.
24. Manfredi R, et al (2005) Endometrial cancer: magnetic resonance imaging. Abdom Imaging 30: 626-636.
25. Kato S, et al (2010) CT-based 3D dose-volume parameter of the rectum and late rectal complication in patients with cervical cancer treated with high-dose-rate intracavitary brachytherapy. J Radiat Res 51: 215-221.
26. Georg P, et al (2009) Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy. Radiother Oncol 91: 173-180.
27. Noda S, et al (2007) Late rectal complications evaluated by computed tomography-based dose calculations in patients with cervical carcinoma undergoing high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 69: 118-124.
28. Kaplan EL and Meier P (1958) Nonparametric estimation form incomplete observations. J Am Stat Assoc 53: 457-481.
29. Teshima T, et al (1994) Modified Inoue applicator for endometrial brachytherapy. Radiat Med 12: 285-287.